Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 1
1995 2
1996 2
1997 2
1998 6
1999 5
2000 6
2001 5
2002 5
2003 7
2004 14
2005 10
2006 10
2007 8
2008 16
2009 12
2010 10
2011 10
2012 16
2013 13
2014 8
2015 9
2016 6
2017 8
2018 7
2019 4
2020 7
2021 9
2022 12
2023 8
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
Tur C, Carbonell-Mirabent P, Cobo-Calvo Á, Otero-Romero S, Arrambide G, Midaglia L, Castilló J, Vidal-Jordana Á, Rodríguez-Acevedo B, Zabalza A, Galán I, Nos C, Salerno A, Auger C, Pareto D, Comabella M, Río J, Sastre-Garriga J, Rovira À, Tintoré M, Montalban X. Tur C, et al. Among authors: nos c. JAMA Neurol. 2023 Feb 1;80(2):151-160. doi: 10.1001/jamaneurol.2022.4655. JAMA Neurol. 2023. PMID: 36534392 Free PMC article.
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.
Hartung HP, Benedict RHB, Berger T, Bermel RA, Brochet B, Carroll WM, Freedman MS, Holmøy T, Karabudak R, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Wuerfel J, Clinch S, Kadner K, Kuenzel T, Kulyk I, Raposo C, Thanei GA, Killestein J. Hartung HP, et al. Among authors: nos c. Neurology. 2024 Dec 24;103(12):e210049. doi: 10.1212/WNL.0000000000210049. Epub 2024 Dec 3. Neurology. 2024. PMID: 39626127 Free PMC article. Clinical Trial.
Age-Related Disability Outcomes After a First Demyelinating Event.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, Ariño H, Auger C, Villacieros-Álvarez J, Bollo L, Castilló J, Comabella M, Espejo C, Fernández V, Guio-Sánchez C, Galan I, La Puma D, Midaglia LS, Mongay-Ochoa N, Vilaseca A, Arevalo Navines MJ, Nos C, Pappolla A, Rio J, Rodriguez Acevedo B, Zabalza A, Vidal-Jordana A, Pareto D, Sastre-Garriga J, Rovira À, Montalban X, Tintore M. Cobo-Calvo A, et al. Among authors: nos c. Neurology. 2025 Feb 25;104(4):e210305. doi: 10.1212/WNL.0000000000210305. Epub 2025 Feb 4. Neurology. 2025. PMID: 39903901
[Prophylactic hysterectomy (Lynch syndrome, BRCA and others)].
Maudot C, Koual M, Azaïs H, Benoit L, Bentivegna E, Nguyen-Xuan HT, Mereaux J, Bailleul A, Nos C, Moliere D, Bats AS. Maudot C, et al. Among authors: nos c. Bull Cancer. 2025 Mar;112(3):326-334. doi: 10.1016/j.bulcan.2024.08.007. Bull Cancer. 2025. PMID: 40049800 Review. French.
[Lynch syndrome and endometrial cancer].
Bats AS, Rossi L, Le Frere-Belda MA, Narjoz C, Cournou C, Gosset M, Ngo C, Delomenie M, Nos C, Blons H, Laurent-Puig P, Lecuru F. Bats AS, et al. Among authors: nos c. Bull Cancer. 2017 Dec;104(12):1013-1021. doi: 10.1016/j.bulcan.2017.06.018. Epub 2017 Oct 21. Bull Cancer. 2017. PMID: 29061399 Review. French.
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS. Hartung HP, et al. Among authors: nos c. J Neurol. 2024 Jul;271(7):4348-4360. doi: 10.1007/s00415-024-12326-z. Epub 2024 Apr 22. J Neurol. 2024. PMID: 38649522 Free PMC article. Clinical Trial.
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study.
Tur C, Carbonell-Mirabent P, Otero-Romero S, Cobo-Calvo Á, Arévalo MJ, Ariño H, Arrambide G, Auger C, Carvajal R, Castilló J, Comabella M, Galán I, Midaglia L, Nos C, Pappolla A, Pareto D, Río J, Rodríguez-Acevedo B, Saez de Gordoa E, Vidal-Jordana Á, Zabalza A, Sastre-Garriga J, Rovira À, Montalban X, Tintoré M. Tur C, et al. Among authors: nos c. Lancet Reg Health Eur. 2025 Apr 19;53:101302. doi: 10.1016/j.lanepe.2025.101302. eCollection 2025 Jun. Lancet Reg Health Eur. 2025. PMID: 40291402 Free PMC article.
[Breast-conserving therapy of breast cancer].
Doridot V, Nos C, Aucouturier JS, Sigal-Zafrani B, Fourquet A, Clough KB. Doridot V, et al. Among authors: nos c. Cancer Radiother. 2004 Feb;8(1):21-8. doi: 10.1016/j.canrad.2003.10.008. Cancer Radiother. 2004. PMID: 15093197 Review. French.
228 results